|
Article |
Issue |
 |
How complacency in Southeast Michigan's business community could open the doors to terrorist attacks on our vital infrastructure.
By John Sitkiewicz
|
December 2008 |
 |
Widely Regarded as the father of Lipitor, Roger Newton is back at the helm of life-sciences company Esperion Therapeutics. His Mission: develop new drugs to stave off heart attacks and strokes.
By Candace Stuart
|
November 2008 |
 |
A relatively new muscle malady, fibromyalgia is no figment of the imagination. Here’s how some Michigan doctors are helping prevent it from becoming a fixture in the workplace.
By Lisa Brody
|
November 2008 |
 |
Michigan nanotechnology companies are hard at
work developing some potentially revolutionary
new medical products they hope will soon hit the
marketplace.
By Candace Stuart
|
October 2008 |
 |
Michigan’s 36-year-old lottery is a state-operated cash cow that ostensibly
benefits public education. But would the state and its citizenry be better off
if it were simply privatized?
By George Bullard
|
September 2008 |
 |
Profits and productivity throughout Michigan and across America are being challenged like never before as longer hours and more demanding schedules compete with a good night’s sleep.
By Alan Fisk
|
September 2008 |
 |
A new type of addict is coming to the forefront — the workaholic — and Michigan’s challenging economy may be contributing to the problem.
To some, eight-hour days are considered mere half-days on the road to success.
By Lisa Brody
|
July / August 2008 |
 |
Michigan’s universities are developing innovative new methods to detect and treat disease with inventions that are migrating from the laboratory to the marketplace.
By Candace Stuart
|
July / August 2008 |
 |
Thanks to tighter federally mandated fuel-economy standards for model year 2020, the race to develop gasoline alternatives is now more frenzied than ever.
By Gary Witzenburg
|
May / June 2008 |
 |
Michigan may not be mired in just another declining economic cycle. It appears
the Great Lakes state is in the midst of an indeterminate downward trend.
By David Littmann
|
May / June 2008 |
|
|
